Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer.

Journal: Journal of visualized experiments : JoVE
Published Date:

Abstract

Since their approval for clinical use, da Vinci surgical robots have shown great advantages in gastrointestinal surgical operations, especially in complex procedures. The high-quality 3-D visual, multijoint arm and natural tremor filtration allow the surgeon to expose and dissect more accurately with minimal invasion. Total mesorectal excision is the standard surgical technique for the treatment of resectable rectal cancer. To reduce the lateral recurrence rate, lateral pelvic lymph node dissection can be performed, as it is a safe and feasible procedure for locally advanced middle-low rectal cancer with a high possibility of metastasis to the lateral lymph nodes. However, the complexity of the anatomic structures and the high postoperative complication rate limit its application. Recently, several surgeons have increasingly used robotic techniques for total mesorectal excision and lateral pelvic lymph node dissection. Compared with open and laparoscopic surgery, the robotic technique has several advantages, such as less blood loss, fewer blood transfusions, minimal trauma, shorter postoperative hospitalization, and quicker recovery. A robotic approach is generally regarded as a reasonable alternative for complicated procedures such as lateral pelvic lymph node dissection, although there are a limited number of high-quality prospective randomized controlled studies reporting direct evidence. Here, we provide the detailed steps of robot-assisted total mesorectal excision and lateral pelvic lymph node dissection performed at the First Affiliated Hospital of Xi'an Jiaotong University.

Authors

  • Chenhao Hu
    Department of General Surgery, The First Affiliated Hospital of Xian Jiaotong University; Center for Gut Microbiome Research, Med-X Institute, The First Affiliated Hospital of Xian Jiao tong University; Department of High Talent, The First Affiliated Hospital of Xian Jiaotong University.
  • Zhe Zhang
    Department of Urology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China.
  • Lei Zhang
    Division of Gastroenterology, Union Hospital, Tongji Medical College Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Ruihan Liu
    Center for Gut Microbiome Research, Med-X Institute, The First Affiliated Hospital of Xian Jiao tong University; Department of High Talent, The First Affiliated Hospital of Xian Jiaotong University.
  • Jun Yan
    Department of Statistics, University of Connecticut, Storrs, CT 06269, USA.
  • Qi Sun
    Department of Orthopedics, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Shanghai, 200072, P.R.China.
  • Guanghui Wang
    School of Engineering, University of Kansas, Lawrence, KS, United States of America.
  • Junjun She
    Department of General Surgery, The First Affiliated Hospital of Xian Jiaotong University; Center for Gut Microbiome Research, Med-X Institute, The First Affiliated Hospital of Xian Jiao tong University; Department of High Talent, The First Affiliated Hospital of Xian Jiaotong University; junjunshe1975@sina.com.